IDH2 and glioblastoma: As a result, glioblastomas lacking mutations in IDH frequently exhibit elevated levels of epidermal growth factor receptor (EGFR) amplification, alterations in the promoter region of telomerase reverse transcriptase (TERT), and deletion of phosphatase and tensin homolog deleted on chromosome ten (PTEN) [4-7].